Rockefeller Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-105
| Closed | -$4K | – | 4093 |
|
|
2022
Q4 | $4K | Sell |
105
-101
| -49% | -$3.85K | ﹤0.01% | 3412 |
|
|
2022
Q3 | $13K | Sell |
206
-99
| -32% | -$6.25K | ﹤0.01% | 2987 |
|
|
2022
Q2 | $20K | Buy |
305
+94
| +45% | +$6.16K | ﹤0.01% | 2761 |
|
|
2022
Q1 | $17K | Buy |
211
+19
| +10% | +$1.53K | ﹤0.01% | 2811 |
|
|
2021
Q4 | $28K | Buy |
192
+50
| +35% | +$7.29K | ﹤0.01% | 2485 |
|
|
2021
Q3 | $25K | Sell |
142
-7
| -5% | -$1.23K | ﹤0.01% | 2495 |
|
|
2021
Q2 | $24K | Sell |
149
-186
| -56% | -$30K | ﹤0.01% | 2412 |
|
|
2021
Q1 | $57K | Sell |
335
-180
| -35% | -$30.6K | ﹤0.01% | 1840 |
|
|
2020
Q4 | $113K | Buy |
515
+159
| +45% | +$34.9K | ﹤0.01% | 1395 |
|
|
2020
Q3 | $59K | Buy |
356
+311
| +691% | +$51.5K | ﹤0.01% | 1459 |
|
|
2020
Q2 | $5K | Buy |
+45
| New | +$5K | ﹤0.01% | 2120 |
|
|
2019
Q4 | – | Sell |
-1,153
| Closed | -$90K | – | 2253 |
|
|
2019
Q3 | $90K | Buy |
+1,153
| New | +$90K | ﹤0.01% | 826 |
|